Frontiers in Pharmacology
Hepatoprotective effects of empagliflozin in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of preclinical studies
By Lashin S. Ali, Mohamed O. Mostafa, Dana K. Alsharayiah, Show 11 more authorsMamdouh Basheir Eldesoqui
ReviewInterventions
The paper
Al-Ahliyya Amman University; Almaarefa University
Frontiers in Pharmacology, 24 Jul 2026
